{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:15:12Z","timestamp":1784333712220,"version":"3.55.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.euroneuro.2020.01.016","type":"journal-article","created":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T17:09:38Z","timestamp":1581354578000},"page":"158-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Longitudinal effects of clozapine concentration and clozapine to N-desmethylclozapine ratio on cognition: A mediation model"],"prefix":"10.1016","volume":"33","author":[{"given":"Francesco","family":"Dal Santo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Jarratt-Barnham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Gonz\u00e1lez-Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Paz","family":"Garc\u00eda-Portilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2187-4033","authenticated-orcid":false,"given":"Julio","family":"Bobes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Fern\u00e1ndez-Egea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2020.01.016_bib0001","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1017\/S0033291717003774","article-title":"Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?","volume":"48","author":"Ballesteros","year":"2018","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2020.01.016_bib0002","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.euroneuro.2019.06.006","article-title":"A cross sectional study of impact and clinical risk factors of antipsychotic-induced OCD","volume":"29","author":"Biria","year":"2019","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2020.01.016_bib0003","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/FTD.0b013e3181dad1fb","article-title":"Plasma clozapine, norclozapine, and the clozapine:norclozapine ratio in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 1993\u20132007","volume":"32","author":"Couchman","year":"2010","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.euroneuro.2020.01.016_bib0004","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00213-004-2017-1","article-title":"The highly efficacious actions of N-desmethylclozapine at muscarinic receptors are unique and not a common property of either typical or atypical antipsychotic drugs: Is M1 agonism a pre-requisite for mimicking clozapine's actions?","volume":"178","author":"Davies","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2020.01.016_bib0005","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1017\/S003329171800017X","article-title":"Distinct risk factors for obsessive and compulsive symptoms in chronic schizophrenia","volume":"48","author":"Fernandez-Egea","year":"2018","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2020.01.016_bib0006","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1034\/j.1600-0447.107.s416.5.x","article-title":"The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia","author":"Haro","year":"2003","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"10.1016\/j.euroneuro.2020.01.016_bib0007","series-title":"Introduction to Mediation, Moderation, and Conditional Process Analysis","author":"Hayes","year":"2017"},{"key":"10.1016\/j.euroneuro.2020.01.016_bib0009","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/archpsyc.64.6.633","article-title":"Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial","volume":"64","author":"Keefe","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.01.016_bib0010","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.schres.2003.09.011","article-title":"The Brief Assessment of Cognition in Schizophrenia: Reliability, sensitivity, and comparison with a standard neurocognitive battery","volume":"68","author":"Keefe","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2020.01.016_bib0011","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.schres.2018.11.030","article-title":"An investigation into the relationship between clozapine treatment and cognitive performance in patients with treatment resistant schizophrenia","volume":"206","author":"McArdle","year":"2019","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2020.01.016_bib0012","doi-asserted-by":"crossref","first-page":"239","DOI":"10.31887\/DCNS.2019.21.3\/amccleery","article-title":"Cognitive impairment in psychotic illness: Prevalence, profile of impairment, developmental course, and treatment considerations","volume":"21","author":"McCleery","year":"2019","journal-title":"Dialog. Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2020.01.016_bib0013","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.psychres.2017.10.010","article-title":"Plasma ratio of clozapine to N-desmethylclozapine can predict cognitive performance in treatment-resistant psychotic patients","volume":"258","author":"Molins","year":"2017","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2020.01.016_bib0014","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/acps.12374","article-title":"Second-generation antipsychotic effect on cognition in patients with schizophrenia\u2014a meta-analysis of randomized clinical trials","volume":"131","author":"Nielsen","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2020.01.016_bib0015","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.euroneuro.2015.11.006","article-title":"An observational study of clozapine induced sedation and its pharmacological management","volume":"26","author":"Perdigu\u00e9s","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2020.01.016_bib0016","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1176\/appi.ajp.2015.14050673","article-title":"Prediction of working memory performance in schizophrenia by plasma ratio of clozapine to N-desmethylclozapine","volume":"172","author":"Rajji","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.01.016_bib0017","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/JCP.0b013e3181e69060","article-title":"Clozapine and global cognition in schizophrenia","volume":"30","author":"Rajji","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2020.01.016_bib0018","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/JCP.0000000000000847","article-title":"A case study of clozapine and cognition: friend or foe?","volume":"38","author":"Savulich","year":"2018","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2020.01.016_bib0020","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1176\/appi.ajp.2015.15070899","article-title":"Cognition and plasma ratio of clozapine to N-desmethylclozapine in patients with clozapine-resistant schizophrenia","volume":"172","author":"Thornton","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.01.016_bib0021","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00213-004-1940-5","article-title":"The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine","volume":"177","author":"Weiner","year":"2004","journal-title":"Psychopharmacology (Berl)"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X20300419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X20300419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:55:02Z","timestamp":1760378102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X20300419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":19,"alternative-id":["S0924977X20300419"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2020.01.016","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal effects of clozapine concentration and clozapine to N-desmethylclozapine ratio on cognition: A mediation model","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2020.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}